Antimicrobial Catheters Market: Product Innovation and Pipeline Analysis

The global antimicrobial catheters market was valued at USD 1.43 billion in 2025 and is anticipated to grow to USD 2.86 billion by 2033, registering a CAGR of 9.0% from 2026 to 2033. Market expansion is largely attributed to the rising prevalence of hospital-acquired infections, especially catheter-associated urinary tract infections, which impose substantial clinical and financial challenges on healthcare systems globally.

Growing awareness among healthcare professionals and patients regarding infection control, along with the advantages of antimicrobial catheters, is accelerating product adoption. Furthermore, continuous technological innovations—such as the development of catheters coated with silver alloys, antibiotics, and advanced antimicrobial polymers—are improving product performance and lowering infection risks. The increasing elderly population, which is more susceptible to urinary disorders and extended catheter usage, is also driving demand.

Healthcare-associated infections including ventilator-associated events (VAE), catheter-associated urinary tract infections (CAUTIs), and central line-associated bloodstream infections (CLABSI) are major contributors to market growth. These conditions are frequently observed in hospitalized and critically ill patients, resulting in higher morbidity rates, longer hospital stays, and increased healthcare expenditures. Antimicrobial catheters help mitigate these risks by preventing microbial adhesion and biofilm development. The growing incidence of VAEs, CAUTIs, and CLABSIs has heightened the need for advanced antimicrobial catheter solutions, as healthcare providers emphasize patient safety, infection control, and adherence to regulatory standards. Consequently, efforts to reduce such infections continue to support market growth and product innovation.

Download a free sample copy of the Antimicrobial Catheters Market report to explore detailed coverage and inclusions in the final report.

Key Market Trends & Insights

• North America accounted for the highest revenue share of 39.62% in 2025.
• The U.S. represented the largest share within the North American market in 2025.
• By product type, vascular access catheters held the leading revenue share in 2025.
• By technology, the silver-based segment dominated the market in 2025.
• By end use, hospitals captured the largest revenue share in 2025.

Looking for more specific insights? Customize this report to suit your business needs.

Market Size & Forecast

• 2025 Market Size: USD 1.43 Billion
• 2033 Projected Market Size: USD 2.86 Billion
• CAGR (2026–2033): 9.0%
• North America: Largest market in 2025

Explore Grand View Horizon to access global and regional statistics related to the Antimicrobial Catheters Market. It supports cross-segment analysis, geographic comparisons, timeline-based evaluation, and ready-to-use charts for presentations.

Key Antimicrobial Catheters Company Insights

The antimicrobial catheters market remains highly competitive, with leading players focusing on strengthening their positions through both organic and inorganic strategies. These include product innovation, partnerships, mergers and acquisitions, and geographic expansion to address evolving customer requirements.

Key Antimicrobial Catheters Companies

• B. Braun SE
• Teleflex Incorporated
• SilvoGuard
• BD
• MEDLINE
• ConvaTec Group PLC
• Silq Technologies
• AvantGuard (Halomine Inc.)
• Medtronic
• Cook
• Integra LifeSciences Corporation
• Vygon
• Camstent

Recent Developments

• In November 2025, AvantGuard, Inc., a biotechnology firm focused on next-generation antimicrobial solutions inspired by the human immune system, secured three National Institutes of Health (NIH) research grants totaling USD 2.65 million.
• In September 2025, B. Braun SE completed the acquisition of True Digital Surgery (TDS), a company based in Goleta, California, known for its digital robotic-assisted 3D surgical microscopy, reinforcing its capabilities in digital microsurgery.
• In January 2025, BD announced increased investments in its U.S. manufacturing infrastructure for essential medical devices. After investing over USD 10 million in 2024, the company added new syringe and needle production lines in Connecticut and Nebraska, boosting capacity for both safety-engineered and conventional devices. BD also plans to invest more than USD 30 million in 2025 to expand IV line manufacturing in Utah, further enhancing IV catheter production.

Conclusion

The antimicrobial catheters market is poised for steady growth, driven by the increasing burden of healthcare-associated infections and the rising emphasis on infection prevention across healthcare settings. Technological advancements and the development of more effective antimicrobial coatings are expected to further enhance product adoption. Additionally, demographic factors such as an aging population and increased hospitalization rates will continue to support demand. As healthcare providers prioritize patient safety and regulatory compliance, the market is likely to witness sustained innovation, strategic collaborations, and geographic expansion, ensuring long-term growth opportunities.

Looking for a report customized to your requirements? https://www.grandviewresearch.com/services/custom-research

Grand View Research offers

• Focused market intelligence reports on specific geographies or high-growth segments.
• Extended forecast timelines for long-term planning.
• Competitor Benchmarking and Supply Chain Analysis
• Inclusion of regulatory and policy assessments.
• Inclusion of custom data models, KPIs, or applications unique to your business
• Specific high-impact Data Decks and Tables to support effective decision making

And much more…